Segment Reporting – Chemicals*

XLS

 

 

 

 

 

 

 

 

Merck Millipore

Performance Materials

Chemicals

EUR million

Q1
2011

Q1
2010

Q1
2011

Q1
2010

Q1
2011

Q1
2010

*

As a result of the acquisition of Millipore, the Chemicals business sector was reorganized. As of 2011, the Cosmetic Actives business field is reported under the Performance Materials division (previously it was reported under the Merck Millipore division). The figures for 2010 have been adjusted accordingly.

**

Reporting period ending on March 31, 2011. The previous year’s figures as of December 31, 2010 have been adjusted owing to the organizational reassignment of Cosmetic Actives.

Sales

608.4

228.2

408.0

351.4

1,016.4

579.6

Royalty, license and commission income

2.9

1.4

0.7

3.5

3.6

4.9

Total revenues

611.3

229.6

408.7

354.9

1,020.0

584.5

Gross margin

356.3

127.0

264.2

225.9

620.4

352.9

Marketing and selling expenses

–146.1

–57.7

–32.6

–30.5

–178.8

–88.2

Royalty, license and commission expenses

–3.1

–1.7

–1.5

–3.5

–4.6

–5.2

Administration expenses

–28.2

–10.5

–8.7

–9.3

–36.9

–19.8

Other operating expenses and income

–27.1

–14.8

–15.1

–18.3

–42.3

–33.1

Research and development

–32.6

–6.8

–36.5

–31.3

–69.0

–38.1

Operating result

72.0

35.2

168.8

131.5

240.8

166.7

Exceptional items

–

–

157.0

–

157.0

–

Earnings before interest and tax (EBIT)

72.0

35.2

325.8

131.5

397.8

166.7

Net operating assets**

6,208.5

6,435.6

1,312.4

1,289.8

7,520.8

7,725.3

Segment liabilities**

–324.3

–361.4

–143.1

–166.8

–467.4

–528.2

Capital spending on property, plant
and equipment

16.0

7.9

13.3

9.2

29.3

17.1

Investments in intangible assets

1.0

0.7

0.8

0.6

1.7

1.3

Depreciation and amortization

–72.0

–11.6

–27.0

–23.4

–99.0

–35.0

Impairment losses

–

–

–

–9.0

–

–9.0

Net cash flows from operating activities

65.6

30.0

116.9

115.6

182.5

145.6

Net cash flows from investing activities

–14.1

–10.4

181.6

–8.9

167.6

–19.3

Free cash flow

51.5

19.6

298.6

106.7

350.1

126.3

Underlying free cash flow

57.8

19.6

97.6

106.7

155.4

126.3

FCR in %

9.5

8.5

23.9

30.1

15.2

21.6

ROS in %

11.8

15.3

41.3

37.1

23.6

28.5